Timber Pharmaceuticals (TMBR) to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis Jun 20, 2023 08:02AM
Timber Pharmaceuticals Inc. (TMBR) Reports Publication of Results from Phase 2b CONTROL Study of TMB-001 Aug 26, 2022 08:04AM